Latest News about NVO
Recent news which mentions NVO
From Benzinga
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
March 13, 2023
From Benzinga
Jimmy Kimmel Jokes At Oscars About Hollywood Stars Using This Diabetes Drug To Lose Weight — Roasts Will Smith Slap Too
March 13, 2023
Tickers
NVO
From Benzinga
From Benzinga
From Benzinga
Why Weight Watchers is buying a company that prescribes popular weight-loss drugs like Ozempic
March 07, 2023
From MarketWatch
Eli Lilly CEO says $35 for monthly insulin ‘should be the new standard in America’ — and experts say that could happen
March 01, 2023
From MarketWatch
From Benzinga
Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race
February 28, 2023
From Benzinga
This chart gives one reason European stocks may continue to outperform U.S. equities
February 17, 2023
From MarketWatch
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
February 15, 2023
From Benzinga
2 Market-Beating Growth Stocks That Are Just Getting Started
February 10, 2023
From Motley Fool
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
February 10, 2023
From Benzinga
This nearly 150-year-old fund hasn’t cut its dividend since 1938. Here are the stocks it likes, and four it doesn’t.
February 10, 2023
From MarketWatch
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
From Benzinga
The 7 ETFs to Buy for the Perfect Portfolio
February 01, 2023
From InvestorPlace
Novo Nordisk A/s (NVO) Q4 2022 Earnings Call Transcript
February 01, 2023
Tickers
NVO
From Motley Fool
Novo Nordisk Q4 Highlights: Clocks 25% Increase In Sales On Strong Diabetes and Obesity Treatment, Expects 13% - 19% Revenue Growth
February 01, 2023
Tickers
NVO
From Benzinga
Earnings Scheduled For February 1, 2023
February 01, 2023
From Benzinga
Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
February 01, 2023
Tickers
NVO
From MarketWatch
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
From InvestorPlace
3 Global Stocks to Buy to Get Around America’s Slowdown
January 30, 2023
From InvestorPlace
Mr. Beast Video Highlights Major Problem: Billions Will Need Eyecare According To Report
January 30, 2023
From Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years
January 26, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.